Larin 24 fe side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Abnormal withdrawal bleeding (abnormal uterine bleeding)
2. Ankle fracture
3. Anxiety
4. Arthralgia (joint pain)
5. Asthenia (weakness)
6. Blood pressure increased
7. Chest pain
8. Dizziness
9. Drug ineffective
10. Dysmenorrhoea (painful menstruation)

male:

1. Headache (pain in head)
2. Nasal disorder (diseases of nose)
3. Sinusitis (inflammation of sinus)

0-1:

n/a

2-9:

n/a

10-19:

1. Dizziness
2. Menstrual disorder (disease of menstrual cycle)
3. Urinary tract infection

20-29:

1. Complication of device insertion
2. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
3. Abnormal withdrawal bleeding (abnormal uterine bleeding)
4. Acne (skin problems that cause pimples)
5. Drug ineffective

30-39:

1. Staphylococcal infection (an infection with staphylococcus bacteria)
2. Arthralgia (joint pain)
3. Asthenia (weakness)
4. Chest pain
5. Dysmenorrhoea (painful menstruation)
6. Injection site reaction

40-49:

1. Headache (pain in head)
2. Injection site reaction
3. Nasal disorder (diseases of nose)

50-59:

n/a

60+:

n/a

< 1 month:

n/a

1 - 6 months:

1. Asthenia (weakness)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Acne (skin problems that cause pimples)
2. Pain
3. Staphylococcal infection (an infection with staphylococcus bacteria)
4. Abnormal withdrawal bleeding (abnormal uterine bleeding)
5. Ankle fracture
6. Anxiety
7. Arthralgia (joint pain)
8. Blood pressure increased
9. Chest pain
10. Dizziness